Influenza-induced expression of indoleamine 2,3-dioxygenase enhances interleukin-10 production and bacterial outgrowth during secondary pneumococcal pneumonia

Airway infection with influenza virus induces local expression of the tryptophan-catabolizing enzyme indoleamine 2,3-dioxygenase (IDO), which has been shown to enhance inflammatory mediator responses in vitro. Because secondary pneumococcal infections occurring shortly after recovery from influenza...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:The Journal of infectious diseases Ročník 193; číslo 2; s. 214
Hlavní autoři: van der Sluijs, Koenraad F, Nijhuis, Monique, Levels, Johannes H M, Florquin, Sandrine, Mellor, Andrew L, Jansen, Henk M, van der Poll, Tom, Lutter, René
Médium: Journal Article
Jazyk:angličtina
Vydáno: United States 15.01.2006
Témata:
ISSN:0022-1899
On-line přístup:Zjistit podrobnosti o přístupu
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Abstract Airway infection with influenza virus induces local expression of the tryptophan-catabolizing enzyme indoleamine 2,3-dioxygenase (IDO), which has been shown to enhance inflammatory mediator responses in vitro. Because secondary pneumococcal infections occurring shortly after recovery from influenza are associated with enhanced inflammatory responses, we hypothesized that IDO activity contributes to the enhanced response to bacterial challenges in mice previously infected with influenza virus. On day 14 after influenza virus infection (with strain A/PR/8/34), C57Bl/6 mice were intranasally inoculated with 1 x 10(4) colony-forming units of S. pneumoniae (serotype 3). Matrix-driven delivery pellets that contained 70 mg of the IDO inhibitor 1-methyl-DL-tryptophan (MeTrp) released over a period of 7 days were subcutaneously implanted 48 h before pneumococcal infection. MeTrp treatment resulted in a 20-fold reduction in pneumococcal outgrowth 48 h after bacterial inoculation. Remarkably, pulmonary levels of interleukin-10 and tumor necrosis factor-alpha were significantly reduced in mice treated with MeTrp. Our data suggest that IDO expression during influenza virus infection alters the inflammatory response and facilitates the outgrowth of pneumococci during secondary bacterial pneumonia.
AbstractList Airway infection with influenza virus induces local expression of the tryptophan-catabolizing enzyme indoleamine 2,3-dioxygenase (IDO), which has been shown to enhance inflammatory mediator responses in vitro. Because secondary pneumococcal infections occurring shortly after recovery from influenza are associated with enhanced inflammatory responses, we hypothesized that IDO activity contributes to the enhanced response to bacterial challenges in mice previously infected with influenza virus.BACKGROUNDAirway infection with influenza virus induces local expression of the tryptophan-catabolizing enzyme indoleamine 2,3-dioxygenase (IDO), which has been shown to enhance inflammatory mediator responses in vitro. Because secondary pneumococcal infections occurring shortly after recovery from influenza are associated with enhanced inflammatory responses, we hypothesized that IDO activity contributes to the enhanced response to bacterial challenges in mice previously infected with influenza virus.On day 14 after influenza virus infection (with strain A/PR/8/34), C57Bl/6 mice were intranasally inoculated with 1 x 10(4) colony-forming units of S. pneumoniae (serotype 3). Matrix-driven delivery pellets that contained 70 mg of the IDO inhibitor 1-methyl-DL-tryptophan (MeTrp) released over a period of 7 days were subcutaneously implanted 48 h before pneumococcal infection.METHODSOn day 14 after influenza virus infection (with strain A/PR/8/34), C57Bl/6 mice were intranasally inoculated with 1 x 10(4) colony-forming units of S. pneumoniae (serotype 3). Matrix-driven delivery pellets that contained 70 mg of the IDO inhibitor 1-methyl-DL-tryptophan (MeTrp) released over a period of 7 days were subcutaneously implanted 48 h before pneumococcal infection.MeTrp treatment resulted in a 20-fold reduction in pneumococcal outgrowth 48 h after bacterial inoculation. Remarkably, pulmonary levels of interleukin-10 and tumor necrosis factor-alpha were significantly reduced in mice treated with MeTrp.RESULTSMeTrp treatment resulted in a 20-fold reduction in pneumococcal outgrowth 48 h after bacterial inoculation. Remarkably, pulmonary levels of interleukin-10 and tumor necrosis factor-alpha were significantly reduced in mice treated with MeTrp.Our data suggest that IDO expression during influenza virus infection alters the inflammatory response and facilitates the outgrowth of pneumococci during secondary bacterial pneumonia.CONCLUSIONSOur data suggest that IDO expression during influenza virus infection alters the inflammatory response and facilitates the outgrowth of pneumococci during secondary bacterial pneumonia.
Airway infection with influenza virus induces local expression of the tryptophan-catabolizing enzyme indoleamine 2,3-dioxygenase (IDO), which has been shown to enhance inflammatory mediator responses in vitro. Because secondary pneumococcal infections occurring shortly after recovery from influenza are associated with enhanced inflammatory responses, we hypothesized that IDO activity contributes to the enhanced response to bacterial challenges in mice previously infected with influenza virus. On day 14 after influenza virus infection (with strain A/PR/8/34), C57Bl/6 mice were intranasally inoculated with 1 x 10(4) colony-forming units of S. pneumoniae (serotype 3). Matrix-driven delivery pellets that contained 70 mg of the IDO inhibitor 1-methyl-DL-tryptophan (MeTrp) released over a period of 7 days were subcutaneously implanted 48 h before pneumococcal infection. MeTrp treatment resulted in a 20-fold reduction in pneumococcal outgrowth 48 h after bacterial inoculation. Remarkably, pulmonary levels of interleukin-10 and tumor necrosis factor-alpha were significantly reduced in mice treated with MeTrp. Our data suggest that IDO expression during influenza virus infection alters the inflammatory response and facilitates the outgrowth of pneumococci during secondary bacterial pneumonia.
Author van der Sluijs, Koenraad F
Levels, Johannes H M
Mellor, Andrew L
Lutter, René
Nijhuis, Monique
van der Poll, Tom
Florquin, Sandrine
Jansen, Henk M
Author_xml – sequence: 1
  givenname: Koenraad F
  surname: van der Sluijs
  fullname: van der Sluijs, Koenraad F
  email: kvandersluijs@amc.uva.nl
  organization: Department of Pulmonology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. kvandersluijs@amc.uva.nl
– sequence: 2
  givenname: Monique
  surname: Nijhuis
  fullname: Nijhuis, Monique
– sequence: 3
  givenname: Johannes H M
  surname: Levels
  fullname: Levels, Johannes H M
– sequence: 4
  givenname: Sandrine
  surname: Florquin
  fullname: Florquin, Sandrine
– sequence: 5
  givenname: Andrew L
  surname: Mellor
  fullname: Mellor, Andrew L
– sequence: 6
  givenname: Henk M
  surname: Jansen
  fullname: Jansen, Henk M
– sequence: 7
  givenname: Tom
  surname: van der Poll
  fullname: van der Poll, Tom
– sequence: 8
  givenname: René
  surname: Lutter
  fullname: Lutter, René
BackLink https://www.ncbi.nlm.nih.gov/pubmed/16362885$$D View this record in MEDLINE/PubMed
BookMark eNo1kMtOwzAQRb0ooi2PT0BesSLgRxwnS1TxqITEBtaRY09aQzIucSwoH8O3EgSsRjP36OhqlmSGAYGQU84uOSuLq7wqK85nZMGYEBkvq2pOljG-MMZyWehDMueFLERZqgX5WmPbJcBPk3l0yYKj8LEbIEYfkIaWTtfQgek9AhUXMnM-fOw3gCYCBdwatBAnaIShg_TqMeOM7oYwqcYfg0FHG2On2JuOhjRuhvA-bqlLg8cNjWADOjPs6Q4h9cEGayfud0FvjslBa7oIJ3_ziDzf3jyt7rOHx7v16vohsyqvxixvVSUaBmXFnLNacik0yFwwIa2CXIEqbAmtlobZxgoluNaFktbxwjTScXFEzn-9U_W3BHGsex8tdJ1BCCnWhVa6VFxP4NkfmJoeXL0bfD_Vr_8_Kr4B0gt6NA
CitedBy_id crossref_primary_10_1086_591708
crossref_primary_10_1016_j_medmal_2006_05_013
crossref_primary_10_1038_mi_2016_49
crossref_primary_10_1165_rcmb_2006_0166OC
crossref_primary_10_1038_nm1765
crossref_primary_10_2217_fmb_12_29
crossref_primary_10_1007_s00011_024_01878_5
crossref_primary_10_1002_path_5842
crossref_primary_10_1371_journal_pone_0322864
crossref_primary_10_3390_ijms24010038
crossref_primary_10_4049_jimmunol_1700210
crossref_primary_10_1111_febs_15807
crossref_primary_10_1016_j_smim_2009_01_005
crossref_primary_10_1007_s00018_011_0834_z
crossref_primary_10_4049_jimmunol_0801212
crossref_primary_10_3390_v13122362
crossref_primary_10_4049_jimmunol_1300180
crossref_primary_10_1016_j_vetimm_2008_09_016
crossref_primary_10_4049_jimmunol_1301152
crossref_primary_10_1371_journal_pntd_0000264
crossref_primary_10_1186_1471_2334_10_308
crossref_primary_10_1189_jlb_0911474
crossref_primary_10_1002_JLB_4MR0220_446R
crossref_primary_10_1136_thoraxjnl_2013_203728
crossref_primary_10_1038_icb_2009_22
crossref_primary_10_1038_mi_2008_16
crossref_primary_10_1186_s43168_022_00174_2
crossref_primary_10_1038_s41598_019_50618_x
crossref_primary_10_1134_S1607672916060053
crossref_primary_10_3389_fimmu_2018_02943
crossref_primary_10_1093_infdis_jiac325
crossref_primary_10_1371_journal_pone_0021185
crossref_primary_10_1371_journal_ppat_1006955
crossref_primary_10_1371_journal_pone_0058191
crossref_primary_10_1007_s00726_008_0037_6
crossref_primary_10_3390_pathogens11111320
crossref_primary_10_1096_fj_14_254359
crossref_primary_10_1111_j_1600_0684_2009_00395_x
crossref_primary_10_3390_ijms222111714
crossref_primary_10_1073_pnas_1711373114
crossref_primary_10_1016_S2213_2600_14_70131_6
crossref_primary_10_1142_S0192415X08006508
crossref_primary_10_1016_j_imlet_2011_03_008
crossref_primary_10_3109_13693786_2012_710857
crossref_primary_10_1097_INF_0b013e3181a487b4
crossref_primary_10_1111_febs_13966
crossref_primary_10_1007_s00109_007_0262_6
crossref_primary_10_1016_j_it_2012_10_001
crossref_primary_10_3389_fcimb_2021_643326
crossref_primary_10_1093_infdis_jiq095
crossref_primary_10_4049_jimmunol_0902772
crossref_primary_10_1111_j_1600_065X_2012_01149_x
crossref_primary_10_1016_j_coi_2015_02_002
crossref_primary_10_2217_imt_09_21
crossref_primary_10_1093_infdis_jit830
crossref_primary_10_3389_fimmu_2019_00336
crossref_primary_10_1371_journal_pone_0173058
crossref_primary_10_3389_fcimb_2018_00343
crossref_primary_10_1016_j_ijbiomac_2025_141815
crossref_primary_10_1165_rcmb_2008_0202OC
crossref_primary_10_1186_cc9628
crossref_primary_10_2217_fmb_09_3
crossref_primary_10_1111_irv_12174
crossref_primary_10_1097_INF_0b013e3181cdafc2
crossref_primary_10_3389_fimmu_2017_01799
crossref_primary_10_1371_journal_pone_0203521
crossref_primary_10_3390_v13091725
crossref_primary_10_1111_j_1365_2567_2011_03523_x
crossref_primary_10_1371_journal_ppat_1009405
crossref_primary_10_1111_j_1365_3024_2012_01380_x
crossref_primary_10_1016_j_vaccine_2012_09_015
crossref_primary_10_1073_pnas_0914347107
crossref_primary_10_1134_S0006297916110110
crossref_primary_10_1016_j_antiviral_2013_10_001
crossref_primary_10_3389_fcimb_2023_1037850
crossref_primary_10_1371_journal_pone_0066546
crossref_primary_10_2217_fvl_14_65
crossref_primary_10_1111_febs_13997
crossref_primary_10_1183_16000617_0093_2021
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1086/498911
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
Biology
ExternalDocumentID 16362885
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
-DZ
-~X
..I
.2P
.55
.GJ
.I3
.XZ
.ZR
08P
0R~
123
1TH
29K
2AX
2WC
36B
4.4
48X
53G
5GY
5RE
5VS
5WD
70D
85S
AABZA
AACGO
AACZT
AAHBH
AAHTB
AAJKP
AAJQQ
AAMVS
AANCE
AAOGV
AAPNW
AAPQZ
AAPXW
AAQQT
AARHZ
AAUAY
AAUQX
AAVAP
AAWTL
AAYOK
ABBHK
ABDFA
ABEJV
ABEUO
ABGNP
ABIXL
ABJNI
ABKDP
ABLJU
ABNHQ
ABNKS
ABOCM
ABPEJ
ABPLY
ABPPZ
ABPTD
ABQLI
ABQNK
ABTLG
ABVGC
ABWST
ABXSQ
ABXVV
ABZBJ
ACGFO
ACGFS
ACGOD
ACHIC
ACPRK
ACUFI
ACUTO
ACYHN
ADBBV
ADEYI
ADGZP
ADHKW
ADHZD
ADIPN
ADJQC
ADOCK
ADQBN
ADRIX
ADRTK
ADULT
ADVEK
ADYVW
ADZXQ
AEGPL
AEGXH
AEJOX
AEKSI
AEMDU
AENEX
AENZO
AEPUE
AETBJ
AEUPB
AEWNT
AEXZC
AFFNX
AFFZL
AFIYH
AFOFC
AFXAL
AFXEN
AGINJ
AGKEF
AGQXC
AGSYK
AGUTN
AHMBA
AHMMS
AHXPO
AIAGR
AIJHB
AJEEA
ALMA_UNASSIGNED_HOLDINGS
ALUQC
APIBT
APWMN
AQVQM
ATGXG
AXUDD
BAWUL
BAYMD
BCRHZ
BEYMZ
BHONS
BR6
BTRTY
BVRKM
C45
CDBKE
CGR
CS3
CUY
CVF
CZ4
D-I
DAKXR
DCCCD
DIK
DILTD
DOOOF
DU5
D~K
EBS
ECGQY
ECM
EE~
EIF
EJD
EMOBN
ENERS
ESX
F5P
F9B
FECEO
FLUFQ
FOEOM
FOTVD
FQBLK
GAUVT
GJXCC
GX1
H5~
HAR
HQ3
HTVGU
HW0
HZ~
IH2
IOX
IPSME
J21
J5H
JAAYA
JBMMH
JENOY
JHFFW
JKQEH
JLS
JLXEF
JPM
JSG
JSODD
JST
KAQDR
KBUDW
KOP
KQ8
KSI
KSN
L7B
LSO
LU7
M49
MHKGH
MJL
ML0
MVM
N4W
N9A
NEJ
NGC
NOMLY
NOYVH
NPM
NU-
NVLIB
O0~
O9-
OAUYM
OAWHX
OCZFY
ODMLO
OJQWA
OJZSN
OK1
OPAEJ
OVD
OWPYF
P2P
PAFKI
PEELM
PQQKQ
Q1.
Q5Y
QBD
RD5
ROX
ROZ
RUSNO
RW1
RXO
SA0
SJN
TCURE
TEORI
TJX
TR2
VXZ
W2D
W8F
WH7
X7H
X7M
YAYTL
YIF
YKOAZ
YXANX
ZGI
~91
7X8
ABPQP
ADNBA
ADQXQ
AEMQT
AFYAG
AJBYB
AJNCP
ALXQX
JXSIZ
ID FETCH-LOGICAL-c549t-4f592b0e890ddc731327e342023c5e45e56c8ef73a0cbc252177653cd16ab3d12
IEDL.DBID 7X8
ISICitedReferencesCount 92
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000234183200007&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 0022-1899
IngestDate Wed Oct 01 09:17:38 EDT 2025
Wed Feb 19 01:44:45 EST 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c549t-4f592b0e890ddc731327e342023c5e45e56c8ef73a0cbc252177653cd16ab3d12
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://academic.oup.com/jid/article-pdf/193/2/214/2696040/193-2-214.pdf
PMID 16362885
PQID 67578517
PQPubID 23479
ParticipantIDs proquest_miscellaneous_67578517
pubmed_primary_16362885
PublicationCentury 2000
PublicationDate 2006-01-15
PublicationDateYYYYMMDD 2006-01-15
PublicationDate_xml – month: 01
  year: 2006
  text: 2006-01-15
  day: 15
PublicationDecade 2000
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle The Journal of infectious diseases
PublicationTitleAlternate J Infect Dis
PublicationYear 2006
SSID ssj0004367
Score 2.1714132
Snippet Airway infection with influenza virus induces local expression of the tryptophan-catabolizing enzyme indoleamine 2,3-dioxygenase (IDO), which has been shown to...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 214
SubjectTerms Animals
Bronchoalveolar Lavage Fluid - cytology
Delayed-Action Preparations - administration & dosage
Delayed-Action Preparations - pharmacology
Disease Models, Animal
Enzyme Inhibitors - administration & dosage
Enzyme Inhibitors - pharmacology
Female
Indoleamine-Pyrrole 2,3,-Dioxygenase - antagonists & inhibitors
Indoleamine-Pyrrole 2,3,-Dioxygenase - biosynthesis
Indoleamine-Pyrrole 2,3,-Dioxygenase - metabolism
Influenza A virus
Interleukin-10 - analysis
Interleukin-10 - biosynthesis
Lung - immunology
Lung - microbiology
Mice
Mice, Inbred C57BL
Orthomyxoviridae Infections - complications
Orthomyxoviridae Infections - enzymology
Orthomyxoviridae Infections - immunology
Pneumonia, Pneumococcal - etiology
Pneumonia, Pneumococcal - immunology
Pneumonia, Pneumococcal - microbiology
Streptococcus pneumoniae - growth & development
Streptococcus pneumoniae - immunology
Survival Analysis
Tryptophan - administration & dosage
Tryptophan - analogs & derivatives
Tryptophan - pharmacology
Tumor Necrosis Factor-alpha - analysis
Title Influenza-induced expression of indoleamine 2,3-dioxygenase enhances interleukin-10 production and bacterial outgrowth during secondary pneumococcal pneumonia
URI https://www.ncbi.nlm.nih.gov/pubmed/16362885
https://www.proquest.com/docview/67578517
Volume 193
WOSCitedRecordID wos000234183200007&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LS8QwEB5848X3-5WDR4vbpklaEEREUdDFg8LeljSZ6qKm6z7E9cf4W51sW_AiHrwUWtoSmMnMfMnk-wAOKekbnSWWYGrmAYo0QaJ1HBhKL9rmXBg9tvSNajaTViu9m4CT-iyMb6usY-I4UNvC-DXyY-mJ10WoTrtvgdeM8nurlYDGJExzKmR8Q5dq_eAK51LVXOEhwYofykJxmqRh-HtROU4ul4v_G9YSLFRFJTsrvWAZJtCtwGwpMzlagbnbagN9Fb6uS1GSTx0QGCezWoYfVS-sY0XO6GnxgvqV3mbREQ9sp_gYkZNRsmPonryP9JnnmOi94PC54yjAsm7JGuv_oJ1lWUkATQMqhoNHgvmDJ1aehmR9D7-t7o1Y1-HwtaBoTD5S3biOXoOHy4v786ugkmgIDAHLQRDnIo2yBiZpw1qjPA-kQh57TXYjMBYopEkwV1w3TGYiqhWUkoIbG0qdcRtG6zDlCoebwCQKjVJiHqKINbepzY1QkVfRUUhlyxYc1BZo0xTw-xraYTHst2sbbMFGacR2t2TqaFOx6eWUxfaf3-7AfL24EopdmM5p8uMezJj3Qaff2x97Fl2bd7ffSsDdQQ
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Influenza-induced+expression+of+indoleamine+2%2C3-dioxygenase+enhances+interleukin-10+production+and+bacterial+outgrowth+during+secondary+pneumococcal+pneumonia&rft.jtitle=The+Journal+of+infectious+diseases&rft.au=van+der+Sluijs%2C+Koenraad+F&rft.au=Nijhuis%2C+Monique&rft.au=Levels%2C+Johannes+H+M&rft.au=Florquin%2C+Sandrine&rft.date=2006-01-15&rft.issn=0022-1899&rft.volume=193&rft.issue=2&rft.spage=214&rft_id=info:doi/10.1086%2F498911&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-1899&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-1899&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-1899&client=summon